-
3-31-2022 Media Only News Briefing: What you need to know about the COVID-19 BA.2 subvariant
Share this:
On March 31st, 2022, two Mayo Clinic experts offered their insight into the COVID-19 BA.2 subvariant, what effect the subvariant is having on vaccines and boosters, and the role of testing as more options have become available. John (Jack) O'Horo, M.D., an infectious disease specialist and Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory fielded additional questions from the media.
Journalists who have already registered on the News Network can log into their accounts to download a recording of the Zoom briefing found at the end of this post.
Journalists who would like to access the media briefing video can register with the News Network here.
_______________________________
For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding, along with guidelines and recommendations, may have changed since the original publication date.
Share this:
Related articles
Joint development collaboration to bring leading-edge nanopore sequencing into clinical laboratories at Mayo Clinic to increase understanding and improve treatment of cancer and genetic disorders ROCHESTER, ...
In August 2021, then-28-year-old Mike Knudson set out on what he thought would be an adventure-filled hiking vacation inside Glacier National Park in Montana. Little ...
Influenza, respiratory syncytial virus (RSV), and COVID-19 are all part of the seasonal respiratory virus lineup. According to the Centers for Disease Control and Prevention ...